FRACTYL HEALTH, INC. (GUTS)
About FRACTYL HEALTH, INC.
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$141.0M
- Total assets
- $121.4M
- Market cap
- $107.7M
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $0
- Cost of revenue
- $0
- Operating expenses
- $96.8M
- Operating income
- -$96.8M
- Income tax
- $0
- Net income
- -$141.0M
- EPS (basic)
- $-1.86
- EPS (diluted)
- $-1.86
Balance sheet
- Total assets
- $121.4M
- Current assets
- $87.6M
- Total liabilities
- $111.9M
- Current liabilities
- $18.3M
- Shareholders’ equity
- $9.5M
Cash flow
- Operating cash flow
- -$90.3M
- Investing cash flow
- -$557.0K
- Financing cash flow
- $105.0M
- Net cash flow
- $14.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $107.7M
- EPS (diluted)
- $-1.86
- Shares outstanding
- 139.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 2, 2024
Fractyl Health, Inc. (GUTS) Stock Price
- Reported a net loss of $141.0M.
- Trading 68% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review FRACTYL HEALTH, INC..
Write a review
News about FRACTYL HEALTH, INC.
News & sentiment via Polygon.io
Fractyl Health, Inc.: frequently asked questions
Is Fractyl Health, Inc. an American company?
Fractyl Health, Inc. is a US-based company headquartered in Burlington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Fractyl Health, Inc. headquartered?
Fractyl Health, Inc. is headquartered in Burlington, Massachusetts, United States.
Is Fractyl Health, Inc. publicly traded?
Yes — Fractyl Health, Inc. is a publicly traded company. Its stock trades under the ticker symbol GUTS on the NASDAQ.
What does Fractyl Health, Inc. do?
Fractyl Health, Inc. is an American Medical Devices company in the Health & Beauty sector.
